跳至主要内容
临床试验/EUCTR2009-014292-52-GB
EUCTR2009-014292-52-GB进行中(未招募)1 期

Tacrolimus vs prednisolone for the treatment of nephrotic syndrome secondary to minimal change disease: A Randomised Control Trial - Tacrolimus vs prednisolone for minimal change disease

Imperial College NHS trust0 个研究点目标入组 52 人开始时间: 2010年8月4日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients presenting to participating hospital renal clinics with nephrotic syndrome (hypoalbuminaemia and protein creatinine ratio(PCR) >100units), secondary to minimal change disease.
  • Age over 18.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Hepatitis B, hepatitis C or HIV infection
  • 2.Untreated infection
  • 3.Females who are pregnant, breast feeding, or at risk of pregnancy and not using a medically acceptable form of contraception.
  • 4. Patients who have been treated with immunosuppression over the last 18 months.
  • 5. Patients who have had more than 3 relapses of nephrotic syndrome within 5 years
  • 6. Any condition judged by the investigator that would cause the study to be detrimental to the patient

研究者

发起方
Imperial College NHS trust

相似试验

Tacrolimus vs prednisolone for the treatment of... | 临床试验